Latest TCORS News
Adolescents and young adults (AYAs) are aware of and engage in modifications of electronic nicotine delivery systems (ENDS), according to a study published online June 17 in Pediatrics.
- June 17, 2024
As many as four out of every 10 teenagers and young adults who vape are modifying their e-cigarettes in ways that could expose them to burns, lung injury, and covert use of marijuana, a team of Yale Department of Psychiatry scientists found.
- June 13, 2024
In the latest Yale Child Study Center “On Leadership” blog post and newsletter column, Daryn David, PhD reflects on a recent YCSC Grand Rounds session she hosted with Nii Addy, PhD, who serves as the Albert E. Kent Associate Professor of Psychiatry and Associate Professor of Cellular and Molecular Physiology at Yale.
- June 06, 2024
Patients who suffer from the severe skin disorder autoimmune blistering disease (AIBD) are much more likely to experience depression, anxiety, and eating disorders, according to a new study led by Yale researchers Marney White, PhD, MS, professor of public health and psychiatry, and Mary Tomayko, MD, PhD, associate professor of dermatology and of pathology.
- May 21, 2024Source: HealthDay
“We had a 15 percent difference in quit rates, with those in the medication group having a quit rate of 45 percent,” said lead researcher Lisa Fucito, director of the Tobacco Treatment Service at the Yale Cancer Center in New Haven, Conn.
- May 16, 2024
The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say.
- May 07, 2024Source: JAMA Internal Medicine
Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry, and Lisa Fucito, PhD, associate professor of psychiatry, are co-authors of a commentary in JAMA Internal Medicine that proposes health care professionals and policy makers focus on developing targeted and tailored interventions to address e-cigarette use.
- May 01, 2024Source: Yale News
Using multiple nicotine products can be associated with higher levels of nicotine dependence among youth and increased mortality in adults, compared with the use of one product alone, according to a recent study in Preventive Medicine. Patricia Simon, PhD, assistant professor adjunct of psychiatry, is lead author.
- April 24, 2024
Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and professor in the Child Study Center, of neuroscience and of pharmacology, has been elected to the American Academy of Arts and Sciences.
- April 22, 2024Source: British Journal of Clinical Pharmacology
Julio Nunes, MD, psychiatry resident; Jeremy Weleff, DO, instructor of psychiatry, and Joao De Aquino, MD, assistant professor of psychiatry are co-authors of a review in the British Journal of Clinical Pharmacology that explores the possible role of psychedelics in the management of chronic pain and opioid use disorder.